Stockscreener 앱 받기
10.65
5.03%
0.51
시장 영업 전:
10.68
0.03
+0.28%
Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 3.4%Here's Why - MarketBeat
(ORIC) Trading Report - news.stocktradersdaily.com
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down Following Insider Selling - MarketBeat
Millennium Management LLC Has $223,000 Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Research Analysts Issue Forecasts for ORIC FY2026 Earnings - MarketBeat
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 2,976 Shares - MarketBeat
Oric Pharmaceuticals Elects Directors at Annual Meeting - TipRanks
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now? - sharewise
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down After Insider Selling - Defense World
Dominic Piscitelli Sells 2,600 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock - MarketBeat
Bank of America Corp DE Acquires 28,570 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
Millennium Management LLC Trims Stock Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Brokers Issue Forecasts for ORIC FY2026 Earnings - Defense World
Insider Sell: Dominic Piscitelli Sells Shares of ORIC Pharmaceuticals Inc (ORIC) - GuruFocus
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Buy” from Analysts - Defense World
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of "Buy" from Analysts - MarketBeat
Transcript : ORIC Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap UpStill a Buy? - MarketBeat
Two Sigma Investments LP Decreases Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Bank of America Corp DE - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up – Here’s What Happened - Defense World
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 7.6%Still a Buy? - MarketBeat
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates - mx.advfn.com
Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ORIC Pharmaceuticals Expands Oncology Team with 45,600 Equity Grants for New Clinical Specialists - Stock Titan
ORIC Pharmaceuticals, Inc. announced that it has received $124.999983 million in funding from a group of investors - MarketScreener
Cantor Fitzgerald Estimates ORIC FY2025 Earnings - MarketBeat
Two Sigma Investments LP Decreases Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 3.5%What's Next? - MarketBeat
Two Sigma Advisers LP Acquires 8,300 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Viking Invests $125 Million in ORIC Pharmaceuticals PIPE Financing - Global Legal Chronicle
Wall Street Analysts Predict a 131.33% Upside in Oric Pharmaceuticals (ORIC): Here's What You Should Know - MSN
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap DownTime to Sell? - MarketBeat
ORIC Pharmaceuticals (NASDAQ:ORIC) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
H.C. Wainwright maintains buy rating on ORIC Pharmaceuticals stock By Investing.com - Investing.com Nigeria
BNP Paribas Financial Markets Buys New Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Wedbush Reiterates Outperform Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat
Oric Pharma Stock Hits 3-Month High On Promising Results In Prostate Cancer Trial - MSN
Viking in PIPE Investment in ORIC Pharmaceuticals - Cleary Gottlieb
1.45%
0.86%
자본화:
|
볼륨(24시간):